Increased tissue angiotensin-converting enzyme activity impairs bradykinin-induced dilation of coronary arterioles in obesity

Attila Feher, James Cassuto, Andras Szabo, Vijaykumar Surendrakant Patel, Manjeshwar Vinayak Kamath, Zsolt Bagi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Bradykinin (BK) is a key mediator regulating coronary blood flow. It is degraded by angiotensin-converting enzyme (ACE), but what is unknown is whether enhanced tissue ACE activity interferes with BK-induced coronary vasodilation in obesity. Methods and Results: Coronary arterioles (~100μm) were isolated from rats on a normal or high-fat diet (HFD) and from lean or obese patients undergoing heart surgery (n=74). We found that BK-induced dilation was diminished in the coronary arterioles of HFD rats, when compared with controls. When administered in vitro, the ACE inhibitor, captopril, restored the coronary dilation response to BK in HFD rats, but did not affect control responses. Abundant ACE expression was detected in coronary endothelium, which was associated with increased ACE activity in HFD arterioles, as measured by increased response to the ACE substrate, angiotensin I. Moreover, we found that in the coronary arterioles of obese patients, BK-induced dilation was augmented by in vitro captopril administration. Correspondingly, ACE activity was increased in the coronary arterioles of obese patients when compared with the non-obese. Logistic regression analysis revealed that obese patients taking ACE inhibitors prior to surgery exhibited an enhanced dilation response to BK. Conclusions: We demonstrated augmented tissue ACE activity in the coronary arterioles of obese subjects, which leads to reduced coronary dilation response to BK. We provide a rationale for ACE inhibitor therapy in obese patients to improve dilatation of coronary microvessels. (Circ J 2013; 77: 1867-1876).

Original languageEnglish (US)
Pages (from-to)1867-1876
Number of pages10
JournalCirculation Journal
Volume77
Issue number7
DOIs
StatePublished - Jul 1 2013

Fingerprint

Arterioles
Bradykinin
Peptidyl-Dipeptidase A
Dilatation
Obesity
High Fat Diet
Angiotensin-Converting Enzyme Inhibitors
Captopril
Enzyme Therapy
Angiotensin I
Microvessels
Vasodilation
Thoracic Surgery
Endothelium
Logistic Models
Regression Analysis

Keywords

  • Angiotensin-converting enzyme
  • Bradykinin
  • Coronary microcirculation
  • Obesity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Increased tissue angiotensin-converting enzyme activity impairs bradykinin-induced dilation of coronary arterioles in obesity. / Feher, Attila; Cassuto, James; Szabo, Andras; Patel, Vijaykumar Surendrakant; Kamath, Manjeshwar Vinayak; Bagi, Zsolt.

In: Circulation Journal, Vol. 77, No. 7, 01.07.2013, p. 1867-1876.

Research output: Contribution to journalArticle

@article{bd76b1fece284d4091fd4dfcdad0e2d4,
title = "Increased tissue angiotensin-converting enzyme activity impairs bradykinin-induced dilation of coronary arterioles in obesity",
abstract = "Background: Bradykinin (BK) is a key mediator regulating coronary blood flow. It is degraded by angiotensin-converting enzyme (ACE), but what is unknown is whether enhanced tissue ACE activity interferes with BK-induced coronary vasodilation in obesity. Methods and Results: Coronary arterioles (~100μm) were isolated from rats on a normal or high-fat diet (HFD) and from lean or obese patients undergoing heart surgery (n=74). We found that BK-induced dilation was diminished in the coronary arterioles of HFD rats, when compared with controls. When administered in vitro, the ACE inhibitor, captopril, restored the coronary dilation response to BK in HFD rats, but did not affect control responses. Abundant ACE expression was detected in coronary endothelium, which was associated with increased ACE activity in HFD arterioles, as measured by increased response to the ACE substrate, angiotensin I. Moreover, we found that in the coronary arterioles of obese patients, BK-induced dilation was augmented by in vitro captopril administration. Correspondingly, ACE activity was increased in the coronary arterioles of obese patients when compared with the non-obese. Logistic regression analysis revealed that obese patients taking ACE inhibitors prior to surgery exhibited an enhanced dilation response to BK. Conclusions: We demonstrated augmented tissue ACE activity in the coronary arterioles of obese subjects, which leads to reduced coronary dilation response to BK. We provide a rationale for ACE inhibitor therapy in obese patients to improve dilatation of coronary microvessels. (Circ J 2013; 77: 1867-1876).",
keywords = "Angiotensin-converting enzyme, Bradykinin, Coronary microcirculation, Obesity",
author = "Attila Feher and James Cassuto and Andras Szabo and Patel, {Vijaykumar Surendrakant} and Kamath, {Manjeshwar Vinayak} and Zsolt Bagi",
year = "2013",
month = "7",
day = "1",
doi = "10.1253/circj.CJ-12-1163",
language = "English (US)",
volume = "77",
pages = "1867--1876",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "7",

}

TY - JOUR

T1 - Increased tissue angiotensin-converting enzyme activity impairs bradykinin-induced dilation of coronary arterioles in obesity

AU - Feher, Attila

AU - Cassuto, James

AU - Szabo, Andras

AU - Patel, Vijaykumar Surendrakant

AU - Kamath, Manjeshwar Vinayak

AU - Bagi, Zsolt

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Background: Bradykinin (BK) is a key mediator regulating coronary blood flow. It is degraded by angiotensin-converting enzyme (ACE), but what is unknown is whether enhanced tissue ACE activity interferes with BK-induced coronary vasodilation in obesity. Methods and Results: Coronary arterioles (~100μm) were isolated from rats on a normal or high-fat diet (HFD) and from lean or obese patients undergoing heart surgery (n=74). We found that BK-induced dilation was diminished in the coronary arterioles of HFD rats, when compared with controls. When administered in vitro, the ACE inhibitor, captopril, restored the coronary dilation response to BK in HFD rats, but did not affect control responses. Abundant ACE expression was detected in coronary endothelium, which was associated with increased ACE activity in HFD arterioles, as measured by increased response to the ACE substrate, angiotensin I. Moreover, we found that in the coronary arterioles of obese patients, BK-induced dilation was augmented by in vitro captopril administration. Correspondingly, ACE activity was increased in the coronary arterioles of obese patients when compared with the non-obese. Logistic regression analysis revealed that obese patients taking ACE inhibitors prior to surgery exhibited an enhanced dilation response to BK. Conclusions: We demonstrated augmented tissue ACE activity in the coronary arterioles of obese subjects, which leads to reduced coronary dilation response to BK. We provide a rationale for ACE inhibitor therapy in obese patients to improve dilatation of coronary microvessels. (Circ J 2013; 77: 1867-1876).

AB - Background: Bradykinin (BK) is a key mediator regulating coronary blood flow. It is degraded by angiotensin-converting enzyme (ACE), but what is unknown is whether enhanced tissue ACE activity interferes with BK-induced coronary vasodilation in obesity. Methods and Results: Coronary arterioles (~100μm) were isolated from rats on a normal or high-fat diet (HFD) and from lean or obese patients undergoing heart surgery (n=74). We found that BK-induced dilation was diminished in the coronary arterioles of HFD rats, when compared with controls. When administered in vitro, the ACE inhibitor, captopril, restored the coronary dilation response to BK in HFD rats, but did not affect control responses. Abundant ACE expression was detected in coronary endothelium, which was associated with increased ACE activity in HFD arterioles, as measured by increased response to the ACE substrate, angiotensin I. Moreover, we found that in the coronary arterioles of obese patients, BK-induced dilation was augmented by in vitro captopril administration. Correspondingly, ACE activity was increased in the coronary arterioles of obese patients when compared with the non-obese. Logistic regression analysis revealed that obese patients taking ACE inhibitors prior to surgery exhibited an enhanced dilation response to BK. Conclusions: We demonstrated augmented tissue ACE activity in the coronary arterioles of obese subjects, which leads to reduced coronary dilation response to BK. We provide a rationale for ACE inhibitor therapy in obese patients to improve dilatation of coronary microvessels. (Circ J 2013; 77: 1867-1876).

KW - Angiotensin-converting enzyme

KW - Bradykinin

KW - Coronary microcirculation

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=84879330091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879330091&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-12-1163

DO - 10.1253/circj.CJ-12-1163

M3 - Article

C2 - 23603844

AN - SCOPUS:84879330091

VL - 77

SP - 1867

EP - 1876

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 7

ER -